Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
RLYB
SELLRallybio Corporation · Healthcare · United States · $87M · Avg Vol: $796K/d
34
StockRankGet insider-trade alerts
Q
26
V
29
M
70
P/E (TTM)
—
ROE
-15.0%
D/E
0.0x
Dividend %
—
Loading 1Y...
PRICE (1Y)+2.4%
SMA 50SMA 200
Close
$16.31
RSI (14)
63.4
52W High
$17.57
From 52W High
0.9%
SCORE BREAKDOWN
Quality
26
ROIC
-55.4%13.9
ROE
-15.0%33.7
GP/Assets
-23.6%4.2
Op. Margin
-3787.5%4.2
FCF/Assets
-28.9%12.0
Piotroski
111.4
Int. Cover
—N/A
D/E Ratio
0.00x90.6
Current Ratio
12.92x90.4
Value
29
P/E (TTM)
—N/A
EV/EBITDA
-1.3x25.0
P/FCF
—N/A
P/B
1.7x66.2
P/S
100.9x7.5
Div Yield
—N/A
Momentum
70
52W High %
93%90.9
RS 6M
196%99.3
SMA 50/200
1.74x99.5
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
-297%1.6
Q Growth
—N/A
FUNDAMENTALS
Market Cap
$87M
P/E (Forward)
-3.0x
Gross Margin
—
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of RLYB are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| RLYB | Rallybio Corporation(you) | $87M | 34 | SELL |
| NRXS | NeurAxis, Inc. | $84M | 33 | SELL |
| SEER | Seer, Inc. | $108M | 34 | SELL |
| LONA | LeonaBio, Inc. | $69M | 30 | SELL |
| ATRA | Atara Biotherapeutics, Inc. | $71M | 29 | SELL |
| XBIT | XBiotech Inc. | $69M | 29 | SELL |
| PTHS | Pelthos Therapeutics Inc. | $90M | 24 | SELL |
| VTVT | vTv Therapeutics Inc. | $121M | 39 | HOLD |
| XLO | Xilio Therapeutics, Inc. | $57M | 38 | HOLD |
| CUE | Cue Biopharma, Inc. | $135M | 30 | SELL |
Peer medians: ROE -25.6% · P/E 27.6x · Gross margin 50.5%